By Krystal Hu Oct 7 (Reuters) - The US government and tech heavyweights Meta Platforms and Google parent Alphabet are joining ...

Myxobacteria are renowned producers of structurally diverse bioactive natural products but are difficult to engineer. Here the authors create a robust heterologous expression chassis and develop ...

Found in 70 percent of cancers, the gene is seen as a grand orchestrator but has been surprisingly difficult to stop.

Major discoveries, including the role of DNA, the biological basis of psychology, and the human genome, missed out on science ...

Biohub, Google, Meta and the U.S. government are investing $1.8 billion to build AI-ready biological data for disease ...

The AI revolution has long been associated with the digital realm – dazzling software, smart algorithms, and the tech giants ...

The three-year initiative, funded by the UK’s Advanced Research and Invention Agency (ARIA), will initially target one of the ...

The discovery of a protein that can, by itself, dictate the sequence of nucleic acids has caused a stir in the scientific ...

Alphabet (GOOGL:NASDAQ) and Meta Platforms (META:NASDAQ) are buying into AI biology. On Wednesday Google DeepMind, Alphabet’s drug discovery unit Isomorphic Labs, and Meta agreed to put a combined ...

Cancer can begin changing at the molecular level long before its presence becomes obvious through conventional clinical signs ...

Biohub, the nonprofit research institute combining AI and biology, has joined the US Department of Energy (DOE), the National ...

Boost ROI through secure automation, ultra-long DNA synthesis, codon optimization, biopharma partnerships, and expansion into synthetic biology and Asia-Pacific marketsDublin, Oct. 08, 2026 (GLOBE ...